A matter of spleen - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

A matter of spleen

Description:

10-day history of loss of appetite, malaise, and weakness ... Lungs: clear to auscultation and percussion bilaterally. Abdomen: soft, nontender, nondistended. ... – PowerPoint PPT presentation

Number of Views:121
Avg rating:3.0/5.0
Slides: 21
Provided by: fsanraffae
Category:

less

Transcript and Presenter's Notes

Title: A matter of spleen


1
A matter of spleen
  • Lorenzo Dagna
  • San Raffaele Scientific Institute
  • Università Vita-Salute San Raffaele
  • Milan, Italy
  • lorenzo.dagna_at_hsr.it

2
Clinical case
  • Male, 66-year old, Italian
  • 10-day history of loss of appetite, malaise, and
    weakness
  • 7 days before admission intermittent high-grade
    fever (39C/102.2F) accompanied by profuse
    sweating, and dyspnea
  • ? Levofloxacin 500 mg daily (started by his GP)
  • No history of recent travels.

3
Past medical history
  • congenital stenosis of pulmonary arteries
    (aneurysm)
  • 1990 diagnosis of idiopathic thrombocytopenic
    purpura (corticosteroids)
  • 1996 splenectomy
  • 1999 vertebral crush fracture (T8)
  • 2000 hyperplastic disease of the prostate
  • 2003 aspecific chronic colitis with colonic
    tubulo-villous adenomatosis (mild dysplasia)
  • 3 months before admission elevated LFTs

4
Physical on admission
  • BP 110/70 mmHg, HR 94/min, T 38.8C (102F)
  • Not in apparent acute distress, alert, oriented
  • Heart tachycardia, regular rhythm, 2/6 systolic
    bruit on right parasternal
  • Lungs clear to auscultation and percussion
    bilaterally
  • Abdomen soft, nontender, nondistended. No
    masses. Bowel sounds within normal limits. Mild
    hepatomegaly
  • Lymph nodes bilateral axillary and inguinal
    lymphadenopathy

5
Laboratory findings
  • Hb 11.6 g/dL (MCV 87.0 fL), Plt 19.000WBC 3.900
    (N62 L36 M2 E0)
  • creatinine 1.18 mg/dLC-reactive protein 55.51
    mg/L (normal values. 2.0-6.0)
  • Na 127.7 mmol/L, K 4.49 mmol/LALT (SGPT) 81 U/L,
    AST (SGOT) 109 U/LLDH 558 U/L
  • serum proteins, 76.8 g/LSPE albumin 34,
    ?-globulin 43.7(monoclonal gammopathy)
  • Immunofixation IgG ? and IgG ?

6
Diagnostic workup
  • Chest X-ray widening of upper cardiac shadow
    (pulmonary artery aneurysm). No
    pleuroparenchimal alterations
  • Abdomen US mild hepatomegaly (16 cm right lobe
    longitudinal diam.) few small hepatic hilar
    lymph-nodes

7
Diagnostic workup
  • 33 blood cultures negative (72hrs)PPD (5U)
    negative
  • ANA 1640 (granular)C3, C4 normal
  • Anti-HIV negAnti-HCV negAnti-HBsAg
    negWidal-Wright, anti-Brucella spp. neg

8
Diagnostic workup
  • Echocardiogram (TTTE)no bacterial
    vegetationscommon pulmonary trunk aneurysm
  • mild tricuspidal insufficiency

9
Diagnostic workup
  • CT scan (thoraxabdomen)
  • Bilateral apical pleural thickening mild
    bilateral pleural and pericardic effusion few
    small mediastinal lymph nodes (diam. lt 1 cm)
    aneurysm of the pulmonary common trunk (diam., 6
    cm)
  • Bilateral iliac lymph nodes (diam., lt 2 cm)
  • Two masses (diam., 4 cm) at the site of
    splenectomy (hypertrophic residual splenic
    tissue)
  • Mild hepatomegaly (no focal lesions) few hilar
    lymph nodes (diam., 1.5 cm)

10
Laboratory findings (day 4)
  • Hb 10.8 g/dL (MCV 86.8 fL) WBC 1.900 (N42 L56
    M2 E0)Plt 8.000
  • creatinine 2.2 mg/dL
  • ? ALT (SGPT) ? AST (SGOT)? LDH

11
A diagnostic procedure was performed
12
Diagnostic procedure
  • A bone-marrow core biopsy was performed
  • Prednisone 1 mg/kg day was started

13
Bone marrow biopsy
Leishmania spp. organisms within mononuclear
cells (Giemsa stain, 400x)
14
Leishmania testing
  • Anti-Leishmania Abs pos 15,120
  • Leishmania spp. PCR assay2,700,000 DNA
    equivalents/plasma mL

15
Diagnosis / Therapy
  • A diagnosis of visceral Leishmaniasis was made
  • Liposomal amphotericin B (3 mg/kg daily for 5
    day, then at day 14 and 21, total 21 mg/kg)

16
Visceral Leishmaniasis
  • Leishmania donovani complex (L. donovani, L.
    infantum, L. chagasi)
  • Transmission sandflies parenterally,
    congenitally
  • Infection Macrophages reticulo-endothelial
    system

17
VL clinical laboratory features
  • Often silent and subclinical(malnutrition is a
    risk factor for the development of the disease)
  • Splenomegaly (soft, non-tender) more impressive
    than hepatomegaly
  • Sometimes peripheral lymphadenopathy
  • Anemia (BM infiltration, hypersplenism,
    autoimmune hemolysis, bleeding)
  • Leukopenia (?N, ?Eo)
  • Thrombocytopenia
  • Hypergammaglobulinemia (polyclonal B-cell
    activation)
  • Hypoalbuminemia

18
VL differential diagnosis
  • Other infectious diseases that may cause fever or
    organomegaly
  • typhoid fever
  • miliary tuberculosis
  • brucellosis
  • histoplasmosis
  • malaria
  • Schistosomiasis
  • Lymphoproliferative diseases
  • leukemia
  • lymphoma

19
VL diagnosis
  • Demonstration of the parasites on stained
    slides(spleen, liver, bone marrow, lymph node)
  • High titers of anti-Leishmania antibodies
  • Leishmania skin-test reactivity
  • IFN-? cellular responses to leishmanial Ags
  • PCR (being field-tested)

20
VL therapy
  • Pentavalent antimonial compounds (SbV) - IV/IM20
    mg SbV/kg qd for 28 days
  • Lipid formulations of amphotericin B - IV2-5
    mg/kg qd (day 1-5, 14 and 21)
  • Paromomycin - IV15-20 mg/kg qd for 21 days
  • Pentamidine - IV, IM4 mg/kg qod or thrice weekly
    for 15-30 doses
  • Miltefosine - PO2.5 mg/Kg qd for 28 days
Write a Comment
User Comments (0)
About PowerShow.com